Lowering the age for mammogram self-referral will lead to more breast cancer screening, which is expected to save lives. It's ...

Study projects rising breast cancer cases in India, with an estimated annual economic burden of $19.55 billion by 2030.

Even if a patient is unable to beat the disease, early-stage detection of cancer can play a crucial role in increasing their ...

Nearly 75% of women treated with a novel vaccine designed to prevent triple-negative breast cancer achieved an immune ...

The increase in breast cancer rates among younger patients is occurring as the incidence of other early-onset cancers — ...

The U.S. Food and Drug Administration has approved AstraZeneca and partner Daiichi Sankyo's precision drug to treat a type of ...

It’s a sobering statistic: 1 in 8 women in the United States will be diagnosed with breast cancer during her lifetime.1 ...

Heart disease increases the likelihood of advanced breast cancer. Hormone receptor-positive tumors are linked to ...

The FDA has approved AstraZeneca and Daiichi Sankyo’s Datroway (datopotamab deruxtecan-dlnk) to treat unresectable or ...

Two new studies have identified a possible way to block the progression of several forms of blood cancer using a drug already in clinical trials against breast cancer.

Dr. Maxwell Lloyd discusses the long-term management of patients with HR-positive, HER2-negative breast cancer who have received Orserdu treatment.

During a Case-Based Roundtable event, Laura Huppert, MD, reviewed antibody-drug conjugates for a patient with metastatic ...